A carregar...
Bortezomib (Velcade™) in the Treatment of Multiple Myeloma
The introduction of bortezomib, a novel first-in-class proteasome inhibitor, has been a major break through in the treatment of multiple myeloma. It is currently approved for the treatment of myeloma in the relapsed setting post transplant or as a second line treatment in patients unsuitable for tra...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1936263/ https://ncbi.nlm.nih.gov/pubmed/18360602 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|